Genentech Receives Subpoena on Rituxan
233661
Biotechnology company Genentech Inc. received a subpoena from the US Attorney&#39;s Office for the Eastern District of Pennsylvania requesting documents related to the promotion
380448
Biotech company OSI Pharmaceuticals Inc. and biotech giant Genentech Inc. reported Friday that the Food and Drug Administration approved their Tarceva cancer treatment for patients with advanced non-small-cell
688355
Genentech Inc.  said on Wednesday that second-quarter profit rose 41 percent, fueled by growth from cancer drugs Rituxan and Avastin.
199041
WASHINGTON - The US Attorney in New York has subpoenaed information from Chiron, the major flu vaccine supplier for the US, on the unexpected shutdown of a plant in Great Britain.
510674
NEW YORK, November 19  - Tarceva, an experimental lung cancer drug, has been approved by the Food &amp; Drug Administration, Genentech (DNA.
108225
Genentech appears to have resolved a dispute with ophthalmologists over use of the companyâs drug Avastin to treat eye diseases.
518558
Biotechnology company InterMune Inc.  on Tuesday said it received a subpoena from the U.S. Department of Justice demanding information related to its key drug Actimmune, which is designed to spur the immune system.
616970
Tercica gets a partnership with Genentech.
137166
(InfoWorld) - The U.S. Department of Justice (DOJ) has subpoenaed Advanced Micro DevicesÂ as part of an antitrust investigation into the market for graphics processors and graphics cards, AMD said Thursday. AMD recently entered the graphics chip business with itsÂ acquisition of ATI Technologies, which was finalized last month. The DOJ has not made any allegations against AMD or ATI, and AMD intends to cooperate with the investigation, it said. While the DOJ hasn't said specifically what it is investigating, one industry analyst speculated that the case could be about price fixing. The DOJ has alreadyÂ charged a number of chip companiesÂ in the DRAMÂ memory chip market for price fixing, and isÂ investigating severalÂ in the SRAM (Static RAM) chip market. "If the DOJ wanted to, it could just go down every line in the semiconductor industry and find the same issue," said Gartner analyst Richard Gordon. That's because there are a relatively few number of suppliers in the chip industry and an open flow of communication between competitors and customers, who may not define price fixing the same way the DOJ does, he said. The investigations are unlikely to benefit end users, according to Gordon. Historically, prices in the chip industry have gone up and down based on supply and demand and he doubts that such investigations will result in lower pricing. A spokeswoman for AMD in Europe, Hollis Krym, said she did not know if the investigation has a broad scope and includes other graphics chip companies or if it is in the context of the ATI acquisition. U.S. antitrust authorities have already approved AMD's merger with ATI. In the DRAM market, the DOJ has charged Samsung Electronics, Hynix Semiconductor America, Elpida Memory, and Infineon TechnologiesÂ with price fixing and sentenced the companies to pay multi-million dollar fines. Sony, Cypress Semiconductor, and the U.S. arms of Mitsubishi Electric, Samsung Electronics, and Toshiba have all been asked to turn over information to the DOJ for an investigation into SRAM price fixing.
283701
GlaxoSmithKline said on Monday that U.S.  regulators were seeking further information prior to the  possible approval of cervical cancer vaccine Cervarix.
764644
GlaxoSmithKline said on Monday that U.S. regulators were seeking further information prior to the possible approval of cervical cancer vaccine Cervarix.
381029
Chiron Corp. said in a regulatory  filing on Tuesday that it received a grand jury subpoena issued  by the U.S. Attorney's Office for the Southern District of New  York requesting documents related to its failure to supply any  flu vaccine this year.
445922
Two lupus patients died from a rare brain infection after taking the Genentech and Biogen Idec drug Rituxan, U.S. health officials said in an advisory issued on Monday.
460110
Biotechnology company InterMune Inc. on Tuesday said it received a subpoena from the US Department of Justice demanding information related to its key drug Actimmune, which is designed to spur the immune system.
617405
Genentech Inc. said on Thursday it has  updated information on the package insert for its colon cancer  drug Avastin to reflect an increased risk of blood clots that  can cause heart attacks and stroke.
390053
Samsung, Micron Technology and Hynix Semiconductor have acknowledged that they have received subpoenas related to the investigation.
606350
Abbott Laboratories filed a New Drug Application with the Food and Drug Administration for its drug Xinlay (atrasentan) to be used as a treatment for metastatic hormone-refractory prostate cancer.